Agent for treating nocturnal pollakiuria
AssigneeKyorin Pharmaceutical Co., Ltd.
InventorsKatsuya Segawa, Takafumi Kurose
Life of this patent
Estimating the term…
Abstract
[Problem] To provide a novel therapeutic agent for nocturnal pollakiuria. [Solution] A therapeutic agent for nocturnal pollakiuria which contains, as an active ingredient, (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide.
Claims4
A method for treating nocturnal pollakiuria, comprising administering to a subject in need thereof (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide in an effective amount to treat nocturnal pollakiuria,
- wherein the effective amount of the (6S)—N-[4-({(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl}methyl)phenyl]-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide is administered to a subject belonging to a group of patients with nocturnal pollakiuria without nocturnal polyuria.
Dependencies are inferred from the claim text.